ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05224	Breast cancer	6/29	174/7206	5.44273582612e-05
ko01522	Endocrine resistance	5/29	124/7206	0.000118682388535
ko04330	Notch signaling pathway	3/29	62/7206	0.00188984366848
ko04910	Insulin signaling pathway	4/29	172/7206	0.00467031292199
ko04530	Tight junction	4/29	228/7206	0.0124527464074
ko04670	Leukocyte transendothelial migration	3/29	151/7206	0.0221255283037
ko05205	Proteoglycans in cancer	4/29	271/7206	0.0221562352695
ko00330	Arginine and proline metabolism	2/29	61/7206	0.0247158402321
ko05221	Acute myeloid leukemia	2/29	63/7206	0.026247123802
ko05206	MicroRNAs in cancer	3/29	177/7206	0.0333405370356
ko04371	Apelin signaling pathway	3/29	177/7206	0.0333405370356
ko04310	Wnt signaling pathway	3/29	181/7206	0.0352870426489
ko05134	Legionellosis	2/29	74/7206	0.0353285063188
ko05214	Glioma	2/29	79/7206	0.0398059843105
ko04072	Phospholipase D signaling pathway	3/29	197/7206	0.0436554185768
ko05200	Pathways in cancer	5/29	492/7206	0.0442239610427
ko05220	Chronic myeloid leukemia	2/29	85/7206	0.0454485843327
ko04062	Chemokine signaling pathway	3/29	201/7206	0.0458915748129
ko05210	Colorectal cancer	2/29	86/7206	0.0464165640756
ko05133	Pertussis	2/29	87/7206	0.0473922179214